Taiwan Advanced Nanotech Inc (6797) Fair Value & Analysis
Healthcare · TW · Market cap 409M TWD
Fair value as of: Jul 12, 2026
From 3 valuation models · updated today
Fair value updated Jul 12, 2026 — revised from 77.08 TWD to 28.77 TWD (−62.7%) since Jun 24, 2026. Share price +3.4% over the past month.
Price vs Fair Value (12 months)
12‑month range 12.45 TWD – 20.50 TWD · fair‑value band 26.43 TWD – 32.31 TWD · the 13.65 TWD price screens below the 28.77 TWD fair value. As of Jul 12, 2026.
✦ Which stocks are undervalued right now? Check free Discover now →Analysis
Taiwan Advanced Nanotech Inc (6797) currently trades at 13.65 TWD, while our model-based Fair Value estimate is 28.77 TWD — implying the stock looks roughly 110.8% undervalued today. We read business quality at 37/100 (below-average quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: low) — always confirm before acting.
Trailing-twelve-month revenue stands at 154M TWD. Revenue declined 16.9% year over year. It earns a return on equity of -25.5%. Net debt stands at 36.8M TWD. Fundamentals as of Jul 12, 2026
Our scenario range runs from 26.43 TWD (bear case) to 32.31 TWD (bull case); at 13.65 TWD, the current price sits below that range. The share trades about 34% below its 52-week high and 14% above its 52-week low, currently below its 200-day average. For context, the median of 10 Healthcare peers we cover trades at -27% fair-value upside — at 111%, 6797 screens cheaper than that median.
Key figures & financial health
More key figures
Figures from reported company fundamentals (EODHD) · as of Jul 12, 2026. TTM = trailing twelve months.
About the company
Taiwan Advanced Nanotech Inc. engages in the development, manufacturing, and sales of various functional nanoparticles and automated nucleic acid extraction equipment in Taiwan. The company provides automated extraction instruments; nucleic acid extraction kit that extracts DNA/RNA from samples of blood, cell, tissue, plant, bacteria, virus, etc.; consumables, such as spin tips and deep well plates; filling line systems; and molecular biology reagents. It also provides OEM/ODM services. The company was founded in 2004 and is based in Taoyuan City, Taiwan.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
Taiwan Advanced Nanotech Inc reported revenue of 154M TWD in FY2025 versus 1.9B TWD in FY2021, a compound −46.8%/yr. Reported net income was −227M TWD in FY2025.
Is 6797 fairly valued? → Check now
Similar stocks
10 more Medical Devices stocks, each showing price versus our Fair Value estimate (as of Jul 12, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Abbott Laboratories, ABTT34 | R$37.76 | R$6.34 | -83% |
| Stryker Corporation S1YK34 | R$77.83 | R$8.47 | -89% |
| Medtronic plc MDT | $81.67 | $60.02 | -27% |
| Boston Scientific Corporation B1SX34 | R$247.01 | R$234.82 | -5% |
| Edwards Lifesciences Corporation EW | $85.88 | $41.02 | -52% |
| Siemens Healthineers AG SEMHF | $39.95 | $44.36 | +11% |
| GE HealthCare Technologies Inc GEHC | $60.64 | $65.03 | +7% |
| DexCom, Inc DXCM | $72.59 | $39.33 | -46% |
| Koninklijke Philips N.V 1PHIA | €24.31 | €9.97 | -59% |
| Shenzhen Mindray Bio-Medical Electronics Co 300760 | ¥141.85 | ¥147.63 | +4% |
Explore undervalued stocks
More undervalued Healthcare stocks →
Frequently asked questions
Is Taiwan Advanced Nanotech Inc (6797) undervalued?
What is the fair value of 6797?
What is the quality score of 6797?
What is the revenue of Taiwan Advanced Nanotech Inc (6797)?
What is the net profit margin of 6797?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Unlock the full Taiwan Advanced Nanotech Inc analysis — and try Pro free
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.
Not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.